RecruitingNot ApplicableNCT06149897

Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).

Feasibility and Effectiveness of Tdcs in a Multimodal Treatment With Health Education and Aerobic Exercise in the Treatment of Post-stroke Fatigue.


Sponsor

Hospital Clinic of Barcelona

Enrollment

54 participants

Start Date

Nov 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to analyze the use of non-invasive brain stimulation (tDCS) is beneficial for the treatment of post-stroke fatigue.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria4

  • First stroke within 45 (+-7) days of the ischemic or hemorrhagic episode.
  • Ability to understand and execute simple instructions
  • Over 18 years.
  • Fatigue Scale of fatigue severity with a score greater than or equal to 24

Exclusion Criteria6

  • A score > 2 on the modified Rankin Scale (mRS) before the stroke.
  • Patients with decompensated cardiorespiratory and/or psychiatric pathology.
  • Comorbidity causing disproportionate fatigue, such as long-term COVID.
  • Patients who are cancer survivors or who are undergoing cancer treatment.
  • Patients with a history of epilepsy or who are taking antiepileptic medication.
  • Patents with major depression.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtDCS

Non invasive brain stimulation with sham and active comparators


Locations(1)

Hospital Clínic de Barcelona

Barcelona, Spain, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06149897


Related Trials